LLS Committing $188 Million
Published: 2018-11-08 |
Source: Leukemia & Lymphoma Society
Driving the dizzying pace of breakthroughs in blood cancer treatments, The Leukemia & Lymphoma Society (LLS) announced today $42 million for 80 blood cancer research teams around the world.
The latest infusion of funding by LLS, the world's largest nonprofit devoted to curing blood cancers, brings the organization's current commitment to more than $188 million in multi-year grants, supporting more than 240 top scientific investigators at the world's more prestigious cancer institutions, including Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Dana-Farber Cancer Institute, City of Hope and Stanford University, as well as institutions in Australia, Europe and Canada.
LLS-supported researchers are advancing new approaches to blood cancers, including immunotherapy, genomics and precision medicine. Importantly, these innovations are now being applied to research and treatments for patients with other cancers and chronic diseases.
"Advances in technology have helped bring a deeper understanding of the drivers of cancer, and we are seeing remarkable progress in our quest for cures," said Louis J. DeGennaro, Ph.D., LLS's president and CEO. "Our longtime vision and investment in innovative research is having an impact on patients today. Remarkably, from the start of 2017 through today, the U.S. Food and Drug Administration (FDA) has approved 32 blood cancer treatments and LLS helped advance 26 of these at some point in their development journey."
Since its start almost 70 years ago, LLS has invested more than $12 billion in cancer research, resulting in game-changing advances; among the latest LLS-supported research projects are efforts to produce the next wave of immunotherapy treatments, new strategies to address the unmet needs of children with acute leukemia, and cures for lethal diseases such as acute myeloid leukemia (AML), myeloma and lymphoma. With 45 new grants supporting early career investigators, we continue to foster the next generation of scientists.